| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.002 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |